MichaelSKarasikMDFASGE

PubMed

• 28 citations
  Efficacy of Endoscopic Submucosal Dissection for Superficial Gastric Neoplasia in a Large Cohort in North America
  Saowanee Ngamruengphong, Lorenzo E. Ferri, Hiroyuki Aihara, Peter V. Draganov, Dennis Yang
  Clinical Gastroenterology and Hepatology. 2021-08-01
• 59 citations
  Endoscopic Submucosal Dissection in North America: A Large Prospective Multicenter Study.
  Peter V. Draganov, Hiroyuki Aihara, Michael Karasik, Saowanee Ngamruengphong, A. Aziz Aadam
  Gastroenterology. 2021-06-01
• 43 citations
  Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts
  Mohammad A. Al-Haddad, Thomas E. Kowalski, Ali A. Siddiqui, Howard Mertz, Damien Mallat
  Endoscopy. 2014-10-14

Abstracts/Posters

• Management of patients with pancreatic cysts using Integrated Molecular Pathology
  Kowalski T, Siddiqui A, Loren D, Mertz H, Mallat D, Haddad N, Malhotra N, Sadowski B, Lybik M, Patel S, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J, Catalano ..., DDW, 5/2015
• Endoscopic Suturing Platform for the Management of Gastric Sleeve Leaks, Abstract presented at LCG, 2015
  Tishler D, Papasavas P, Stone A, Karasik M., LCG, 2015
• Intramural Colonic Hematoma, Case Report.
  Moy B, Olson E, Karasik M., ACG, 2015
• Clinical utility of integrated molecular pathology and Sendai 2012 criteria in determining the malignant potential of pancreatic cysts
  Kowalski T, Loren D, Siddiqui A, Mertz H, Mallat D, Haddad N, Malhotra N, Lybik M, Patel S, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J, Callenberg K, Jackson..., ACG, 10/2014
• Clinical validity of integrated molecular profiling in diagnosing pancreatic lesions: Interim results (N=422) of an outcomes based registry.
  Kowalski T, Loren D, Siddiqui A, Al-Haddad M, Mertz H, Malat D, Haddad N, Mahotra N, Sadowski B, Lybik M, Patel S, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J..., Presented at DDW, 5/6/2014
• Clinical utility of Using second-line Integrated Molecular pathology testing in addition to First-line test algorithms to determine the malignant potential of pancreat...
  Kowalski T, Loren D, Siddiqui A, Al-Haddad M, Mertz H, Malat D, Haddad N, Mahotra N, Sadowski B, Lybik M, Patel S, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J..., DDW, 5/3/2014
• The performance of second-line integrated molecular profiling compared to common, first-line testing risk features in diagnosing and predicting benign and malignant pa...
  Al-Haddad M, Schmidt C.M., Catalano M, Haddad N, Malhotra N, Mertz H, Siddiqui A, Kowalski T, Patel S, Okoh E, Lybik M, Mallat D, Karasik M, Swales C, Linder J, Corcor..., ACG, 10/2013
• Clinical validity of integrated molecular profiling in diagnosing pancreatic lesions: Interim results
  Catalano M, Al-Haddad M, Schmidt C. M., Haddad N, Malhotra N, Mertz H, Siddiqui A, Kowalski T, Patel S, Okoh E, Lybik M, Mallat D, Karasik M, Golioto M, Linder J, Corc..., ACG, 10/2013
• The Use of Temporary Gastric Electrical Stimulation as a Screening Tool in Challenging Patients with Gastroparesis
  Papasavas P, Tishler D, Karasik M, Selden M, Kirton O., Society of American Gastrointestinal Endoscopic Surgeons, San Antonio, TX, 3/30/2011
• Join now to see all